MedAvail falls on plan to exit pharmacy services, SpotRx businesses
19/01/2023 16:34
** Health tech firm MedAvail Holdings Inc's MDVL.O shares
down 10.3% at $0.47
** Company is exiting its pharmacy services and SpotRx
businesses, reducing workforce by about 75% urn:newsml:reuters.com:*:nGNX1W57B2
** MedAvail expects operating expense savings of $35 mln-$37
mln in 2023 vs 2022
** Company continues to expect full-year revenue to be at
least $42 mln vs est $43.7 mln - Refinitiv
** MDVL stock fell 78.6% in 2022
(Reporting by Mrunmayee Aniruddha Kulkarni)
((Mrunmayee.AniruddhaKulkarni@thomsonreuters.com))
Recent news on Medavail Holdings
See all newsBrief: Medavail Holdings Approved Reduction In Force Of About 40% Of Current Full-Time Employees
Brief: MedAvail Announces Agreement With New Orleans-Based St. Thomas Community Health Centers For Deployment Of Two M4 Medcenters
Brief: Medavail Announces Agreement With ASP Cares For Deployment Of Ten M4 Medcenters
Brief: MedAvail Announces Agreement With Oak Lawn Pharmacy For Deployment M4 Medcenters
Brief: Medavail Announces 1-For-50 Reverse Stock Split